Iovance Biotherapeutics, Inc. (IOVA) — DEFA14A Filings
All DEFA14A filings from Iovance Biotherapeutics, Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
IOVA Proxy Statement Filed
— May 17, 2024 Risk: low
IOVA filed a Definitive Proxy Statement (DEFA14A) on May 17, 2024, for its upcoming annual meeting. The filing details the company's governance, executive compe
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX